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Article / Clinical Case Report
ABSTRACT
Rhabdomyosarcoma (RMS) is a rare solid tumor in childhood and adolescence. The higher incidence is predominant during 
the first two decades of life. According to the Intergroup RMS Study Group, the embryonal RMS (ERMS), botryoidal 
variant, constitutes a histological subtype characterized as a “grape-like” lesion of 2.0 cm to 9.5 cm. The treatment 
involves chemotherapy, surgery, and/or radiotherapy. We present the case of a 14-year-old female patient diagnosed 
with ERMS, botryoidal variant, which originated in the uterine cervix with vaginal externalization. The initial therapeutic 
approach comprised an initial prolapsed mass excision followed by Wertheim–Meigs surgery due to the tumor extension. 
No consensual protocol to ERMS treatment is found in the medical literature; however, a combined approach seems to 
offer a better result. The postoperative time period was uneventful and the patient followed an adjuvant therapy with 
vincristine, d-actinomycin, and cyclophosphamide. A comprehensive evaluation of the therapeutic options preserving 
the reproductive function—unfortunately not always possible—is part of a multi-disciplined care team concerning the 
pediatric patients. 
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INTRODUCTION
Soft t issue sarcomas const itute the f i fth 
most common solid tumor type in childhood and 
rhabdomyosarcoma (RMS) is the most common 
type found in the first two decades of life. This 
entity can occur anywhere in the body, except the 
bones.1 RMS occurs mostly in the genitourinary 
tract, with the head and neck as the second most 
common site.2,3 RMS can be associated with specific 
gene changes, such as the activation of KRAS or the 
inactivation of p53. In particular, most embryonal 
rhabdomyosarcomas show a point mutation in 
exon 6 of the p53 gene located on chromosome 17.4 
The Intergroup Rhabdomyosarcoma Study Group 
(IRSG) subdivide the rhabdomyosarcoma into three 
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histological subtypes: (i) embryonal RMS (ERMS), 
botryoid and fusiform variants; (ii) alveolar RMS (ARMS), 
including the solid variant; and (iii) undifferentiated 
RMS.5,6 RMS may metastasize to any tissue or organ 
in the body.1 The EMRS botryoid variant presents as a 
submucosal “grape-like” lesion,7 with a polypoid aspect 
measuring from 2.0 cm to 9.5 cm.8 The multimodal 
treatment includes systemic chemotherapy, surgery, 
and/or radiotherapy for local control. Currently, 
the overall 5-year survival is 82%.9 However, the 
therapeutic side effects include infertility and/or sexual 
dysfunction.10 Polypectomy and cervical conization 
have been performed in cases of localized and purely 
embryonal RMS of the uterine cervix, as an alternative 
to radical hysterectomy.11,12 A radical abdominal 
trachelectomy, with a technique that preserves the 
fertility, was applied as a treatment for embryonal 
rhabdomyosarcoma of the cervix for the first and only 
time in 2009, according to a literature review.10
CASE REPORT
A 14-year-old female patient attended the 
gynecology department reporting discomfort in the 
vaginal introitus for 3 months due to a small bulging 
tumor. Her menarche was at the age of 12 and she 
was nulliparous. She reported two regular menstrual 
cycles every 30 days in this time period. However, 
during the last 3 days, she noticed a worsening 
discomfort in the vaginal introitus through which a 
bulging mass emerged. Although no colic pain was 
referred, a large fleshy mass followed by high-volume 
mucosanguinolent secretion was finally expelled from 
her vagina. The physical examination showed a large, 
foul-smelling, lobed-shaped vaginal exophytic lesion 
of 14 × 10 × 8 cm attached to the uterine cervix by a 
pedicle (Figure 1).
After the ligature of the pedicle, the mass was 
excised. The histological report rendered the diagnosis 
of the botryoid type ERMS. The immunohistochemistry 
was positive for desmin, myogenin, CD34, smooth 
muscle actin, and S-100, and negative for AE1/AE3 and 
EMA. The patient was staged as group III and stage 3 
according to the Intergroup Rhabdomyosarcoma Study 
Group (IRSG).
The chest computed tomography was within the 
normal standards and the magnetic resonance imaging 
(MRI) of the abdomen and pelvis—undertaken 5 days 
after the ligature of the pedicle and 36 days before 
surgery—showed normal uterine retrocervical regions, 
a rectovaginal septum, and an anterior rectosigmoid 
wall also normal, which were different from the 
surgical findings.
A retrospective review of the MRI of the pelvis 
was performed with the surgical and postoperative 
pathological findings. T2-weighted images (axial cut 
T2 and its correspondence in sagittal cut T2) showed 
a uterus with normal dimensions, diffuse thickening 
of the endometrium—more significant in the posterior 
region of the uterine cervix, where there are small 
cysts up to 6 mm in length—and irregular contour of 
the adjacent myometrium, possibly corresponding to 
neoplastic infiltration (Figure 2).
Figure 1. Large, foul-smelling, lobed-shaped vaginal 
exophytic lesion of 14 × 10 × 8 cm attached to the 
uterine cervix by a pedicle.
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A review of the images was extremely important 
for a better understanding of the surgical technique 
adopted during the procedure due to the presence of 
residual tumor. The retrospective analysis may have 
been facilitated by surgical and pathological findings; 
therefore, the surgical decision was adequate in the 
face of the physical examination of the patient’s cervical 
isthmus transition.
Surgery was performed 36 days after the MRI. 
A video laparoscopic radical abdominal trachelectomy 
and pelvic lymphadenectomy were initially proposed; 
however, Wertheim–Meigs surgery was performed due 
to the tumor extension to the lower part of the uterine 
body. The postoperative anatomopathological report 
showed a locally advanced tumor compromising the 
endocervix, as well as the isthmus and endometrium. 
There was no evidence of lymph node involvement, and 
the surgical margins were free of the disease, which 
corresponded to the post-surgical group I IRSG stage.
The postoperative time period was uneventful, 
and the patient was referred to the regional cancer 
center for chemotherapy.
ANATOMOPATHOLOGICAL STUDY
The first surgical excision specimen was a blackish 
bunch-of-grapes-like mass of 14.0 × 10.0 × 8.0 cm 
weighing 0.468 kg (Figure 3A). The cut surface showed 
hardened tissue with necrosis and a fleshy pink center 
(Figure 3B).
Figure 2. A – Axial cut T2 and its correspondence in sagittal cut T2 (B) of the magnetic resonance imaging of the 
pelvis showing a uterus with normal dimensions, diffuse thickening of the endometrium (arrow and circled area)—
more significant in the posterior region of the uterine cervix, and irregular contour of the adjacent myometrium, 
possibly corresponding to neoplastic infiltration.
Figure 3. A – Surgical excision specimen was a blackish bunch-of-grapes-like mass of 14.0 × 10.0 × 8.0 cm weighing 
0.468 kg; B – Hardened tissue with necrosis and a fleshy pink center.
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There were several histological aspects of an 
undifferentiated neoplasia of small, round, blue 
cells with extensive necrosis in the endocervical 
region, probably of embryonal cell origin with foci of 
cartilaginous metaplasia (Figure 4).
Rare elongated cells with eosinophilic cytoplasm, 
consistent with rhabdomyoblastic differentiation were 
also found (Figure 5A). Immunohistochemistry was 
positive for desmin, myogenin (Figure 5B), CD34, 
SMA, and S-100; and negative for AE1/AE3 and EMA. 
Figure 4. Photomicrographs of the undifferentiated neoplasia: A – Subepithelial hypercellular areas (H&E, 40X); 
B – Extensive necro hemorrhagic component of neoplasia (H&E, 40X); C – Foci of cartilaginous metaplasia (H&E,40X); 
D – Prevalence of small, round, blue cells, characterizing a probable neoplasm of embryonal cells (H&E, 100X).
Figure 5. Photomicrographs of the tumor. A – Rare elongated cells with eosinophilic cytoplasm, suggesting 
rhabdomyoblastic differentiation (H&E, 400X); B – Immunohistochemistry positivity for myogenin.
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The patient was classified with group III and stage 3, 
according to the IRSG.
The anatomopathological study of the second 
surgical specimen showed a local ly advanced 
“grape-like” gelatinous tumor involving the endocervix, 
the isthmus, and the endometrium (Figure 6). There 
was no evidence of lymph node involvement and the 
surgical margins were free of the disease.
DISCUSSION
Botryoid sarcoma of the uterine cervix is rare 
and accounts for about 10% of all cases of RMS.13 
It is mostly found in the first two decades of life.1 RMS 
cases usually occur sporadically, with no recognizable 
predisposing or risk factors. However, some cases 
show an association with genetic changes, such as 
the activation of KRAS or the inactivation of p53. 
In particular, most of the ERMS show a point mutation 
in exon 6 of the p53 gene located on chromosome 17.4 
The Li-Fraumeni cancer susceptibility syndrome, 
evident by a cluster of soft tissue malignancies 
(including sarcomas), was discovered in a family as 
being caused by a heterozygous germline mutation of 
p53. Dehner et al.14 also found a relationship between 
the family of blastoma, pleuropulmonary tumors and 
confirmed DICER1 mutations and suggests that RMS 
in children should be managed in a broader context 
to include the possibility of pleuropulmonary blastoma 
familial tumor predisposition syndrome.14 Our patient 
could not be tested for a genetic study due to financial 
constraints.
Embryonal rhabdomyosarcoma arises from 
the unsegmented and undifferentiated mesoderm. 
Microscopically, the tumor cells are small and 
spindle-shaped, and have a deeply acidophilic cytoplasm. 
A highly characteristic feature of botryoid tumors is the 
presence of a dense zone of undifferentiated tumor 
cells immediately beneath the epithelium, a formation 
known as Nicholson’s cambium layer.15
Clinically, a botryoid sarcoma may present as 
abnormal vaginal bleeding, a vaginal mass prolapse, or 
an abdominal–pelvic mass. The immunohistopathology 
is crucial for the diagnosis. The IRSG stages this 
entity by (i) the primary site; (ii) the tumor size; 
(iii) the involvement of lymph nodes; (iv) adjacent 
tissues infiltration; and (v) the presence of metastases.1
Nuclear MRI is the gold standard for distinguishing 
the origin of the tumor (whether the endometrium, 
myometrium, or cervix) and is useful in demonstrating 
the dissemination and involvement of the adjacent 
structures.16 However, in this case, the MRI was done 
36 days before the surgical procedure and showed 
normal uterine retrocervical regions, rectovaginal 
septum, and anterior rectosigmoid wall, which differed 
from the surgical findings. A retrospective review of 
the MRI of the pelvis, performed with the surgical and 
Figure 6. Gross view of the surgical specimen after the 
Wertheim-Meigs surgery showing residual “grape-like” 
gelatinous tumor mass within the uterine cavity (edited 
picture).
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postoperative pathological findings, was extremely 
important for a better understanding of the surgical 
technique, and was therefore adequate in the face 
of the physical examination of the patient’s cervical 
isthmus transition.
Girls and young women with RMS of the genital 
tract have an overall 5-year survival of 82%.9
According to the current knowledge, the 
treatment options for botryoid sarcoma of the uterine 
cervix include radical surgery, fertility-sparing surgery, 
chemotherapy, and a combined approach. The ideal 
management of these tumors is not yet established; 
however, the combined therapy seems to result in a 
better outcome.17
The risk of relapse, the neoplastic infiltration of the 
uterine body detected during the video laparoscopic 
trachelectomy, and the previous consent of the patient 
to an extensive procedure led the surgical team to the 
Wertheim–Meigs approach, hopefully with an excellent 
outcome.
With regard to the ideal adjuvant treatment 
regimen, there is still no robust evidence available. 
Notwithstanding, vincristine, d-actinomycin, and 
cyclophosphamide (VAC), is the chemo regimen mostly 
used with a better prognosis. Pelvic irradiation could be 
proposed as an alternative to adjuvant chemotherapy. 
However, this modality of treatment may interfere with 
the patient’s ovarian function.18
A comprehensive evaluation of the impact of 
various therapeutic measures on the health (general, 
sexual, and reproductive) of the patient relies on a 
multidisciplinary study in cases of RMS of the uterine 
cervix of pediatric patients. In properly selected cases 
where the uterine involvement is not present, radical 
trachelectomy could be an attractive therapeutic 
option. In the present case, it was not possible to 
assure an ideal local control of the disease preserving 
the future fertility of the patient. The chosen treatment 
prioritized better prognosis and patient survival time.
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